Clinical studies conducted by ALYATEC are offered to individuals sensitive to allergens (such as pollen, pets, dust mites, or food) and affected by allergic conditions such as asthma, rhinitis, conjunctivitis, anaphylaxis, or eczema. Some studies also involve individuals with chronic rhinosinusitis or severe asthma.
These clinical studies are carried out at our facilities in Strasbourg, over one or several days, and under the supervision of a team of medical and clinical experts.
Participation in any ALYATEC clinical study is compensated.
Visit the “Volunteers’ Testimonials” page to discover our studies as described by the participants.
Would you like to get enrolled in a study ?
What is a clinical study for?
By participating in clinical trials conducted by ALYATEC, you will contribute to improve care and knowledge on allergic and respiratory diseases.
These clinical studies allow the development of pharmaceutical treatments against allergies as well as alternative solutions such as medical devices, air purifiers, dietary supplements or cosmeceuticals.
ALYATEC clinical studies are performed to evaluate the efficacy, safety, formulation or tolerance of the solutions mentionned above.
Can you participate in a clinical study?
ALYATEC is looking for individuals with allergic or respiratory conditions:
- You are between 5 and 65 years old.
- You are allergic to dust mites and/or cat dander and/or pollens (birch, grasses, etc.) and/or certain foods (peanuts, hazelnuts, walnuts, sesame, fish, soy, egg, wheat, etc.).
- You experience symptoms of rhinitis and/or conjunctivitis and/or asthma and/or eczema.
- You are not allergic but have chronic rhinosinusitis, atopic dermatitis, or severe asthma.
If you meet the criteria for our study protocols, you can become an active contributor to biomedical research and take part in the development of new solutions for allergic and respiratory diseases.
Who decides on my involvment in a clinical study?
Your decision to participate must be completely intentional and arising from youself.
If you decide to participate, you will sign information and consent forms.
For additional information, contact ALYATEC by phone at 03 67 68 00 90 or through our contact form.
Are your expenses refunded ?
All studies are financially compensated from up to 6 000 € per year.
This allowance is non-taxable and paid once the final medical checks have been carried out at the end of the study.
It cannot exceed 6 000 € annually. Travel expenses might be refunded as well (on request and under specific conditions).
How is running a clinical trial in ALYATEC?
Medical check up & Registration – 30 minutes
A appointment will be carried out before the clinical trial itself. It allows to :
- Do your administrative registration
- Introduce ALYATEC clinical research center and reply to your questions
- Assess your allergic profile and overall health status.
- Present the clinical study in which you could participate
At the end of this appointment, and with your consent, you will be registered in our volunteer database. This will allow us to contact you as soon as you are eligible for one of our studies and invite you to participate.
This first visit is not compensated.
You can make this first apointment here : Make an appointment
If you agree to participate in a study, several visits will be scheduled, potentially including allergen exposures in ALYATEC environmental exposure unit.
First study visit: Selection – 30 minutes to 1 hour
You have received an email from ALYATEC offering you the opportunity to participate in a study. If you wish to be included in the study, you will then attend a “Selection” appointment:
- Presentation of the study procedures, answers to all your questions, signing of the consent form;
- Verification of the study eligibility criteria;
- Medical visit and blood sample;
- Training in the use of the equipment and recommendations;
- If you agree to participate in the study, several visit dates will be offered to you according to your availability.
Compensation: €30–100, depending on the studies.
Other study visits: 30 minutes to 4 hours
Specific to each study, one or more additional visits are required to confirm your participation in the study, to administer a product to you, to assess its effectiveness, or to ensure medical follow-up.
Compensation: €30–200 per visit, depending on the studies.
Allergen exposure session in ALYATEC
Some studies require the use of the environmental exposure chamber.
Throughout this visit, you will undergo different types of examinations under the constant supervision of a doctor and nurses who are accustomed to treating allergic reactions.
In order to guarantee the quality of the allergen exposure and to prevent you from being a source of contamination, we will provide you with a full-body gown, impermeable to particles, to be worn over your clothes before entering the exposure chamber and to be removed when leaving.
Exposure to allergens is carried out in a room with a surface area of 65 m², equipped with 20 armchairs providing you with optimal comfort.
Various clinical assessments will then be carried out in the exposurechamber and then in the monitoring room in order to control your allergic reactions and the development of symptoms.
Depending on the duration of this day, a meal may be served to you and will be covered by ALYATEC.
Compensation: €150–300 per visit, depending on the studies.
What are the risks of a clinical trial?
Health and Safety
Your safety and well-being are our priority.
During your time at the ALYATEC site, you will be under the constant supervision of doctors and nurses who are accustomed to treating allergic and respiratory diseases.
ALYATEC complies with the regulatory framework established by the competent health authorities for clinical trials (ANSM, CPP, CNIL and ARS). Regulatory approvals are delivered prior to each clinical trial.
Allergen-related effects
The exposure to allergen will cause common allergic symptoms well known to both the participant himself and our medical staff.
The quantities of allergens dispersed in the chamber are similar to those found in the patients’ everyday indoor and/or outdoor environment. There is no allergen overexposure. Our aim is to recreate usual environmental conditions, but in a fully controlled environment.
Drug-related effects
Before each study, the medical team in charge of the study will clearly explain known and expected effects of the experimental product.
Our medical team takes care of volunteers during the whole day of exposure and by phone after the exposure to ensure an optimal medical monitoring and follow-up.
Click here to participate in a clinical trial
